PONATINIB is a Schedule H drug.
Category: BCR-ABL TYROSINE KINASE INHIBITORS
Drug Classification
NILOTINIB
NILOTINIB is a Schedule H drug.
BOSUTINIB
BOSUTINIB is a Schedule H drug.
IMATINIB
IMATINIB is a Schedule H drug.
DASATINIB
DASATINIB is a Schedule H drug.